aica ribonucleotide has been researched along with Cirrhosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, RF; Piao, CS; Xiao, H; Zhang, YY | 1 |
| Cieslik, KA; Entman, ML; Trial, J | 1 |
| Beauloye, C; Bertrand, L; Daskalopoulos, EP; Dufeys, C; Horman, S | 1 |
| Asakura, M; Asanuma, H; Fujita, M; Ito, S; Kim, J; Kitakaze, M; Komamura, K; Minamino, T; Mochizuki, N; Ogai, A; Sanada, S; Sasaki, H; Sugimachi, M; Takahama, H; Takashima, S; Wakeno, M | 1 |
1 review(s) available for aica ribonucleotide and Cirrhosis
| Article | Year |
|---|---|
AMPK in cardiac fibrosis and repair: Actions beyond metabolic regulation.
Topics: Aging; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Berberine; Cardiomegaly; Extracellular Matrix Proteins; Fibrosis; Gene Expression Regulation; Humans; Metformin; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Resveratrol; Ribonucleotides; Signal Transduction; Stilbenes; Thiazolidinediones; Wound Healing | 2016 |
3 other study(ies) available for aica ribonucleotide and Cirrhosis
| Article | Year |
|---|---|
[AMP-activated kinase activation inhibits transforming growth factor-β1 production in cardiac fibroblasts via targeting C/EBPβ].
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Angiotensin II; Animals; Binding Sites; CCAAT-Enhancer-Binding Protein-beta; Cells, Cultured; Fibroblasts; Fibrosis; Heart; Mice; Myocardium; Phosphorylation; Ribonucleotides; Transfection; Transforming Growth Factor beta1 | 2017 |
Aicar treatment reduces interstitial fibrosis in aging mice: Suppression of the inflammatory fibroblast.
Topics: Aging; Aminoimidazole Carboxamide; Animals; Biomarkers; Cell Count; Fibroblasts; Fibrosis; Inflammation; Male; Mice, Inbred C57BL; Myocardium; Ribonucleotides | 2017 |
Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Apoptosis; Cardiotonic Agents; Cells, Cultured; Disease Progression; Dogs; Drug Evaluation, Preclinical; Fibrosis; Gene Expression Regulation; Heart Failure; Insulin Resistance; Metformin; Myocytes, Cardiac; Natriuretic Peptides; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Protein Processing, Post-Translational; Pyrazoles; Pyrimidines; Rats; Rats, Wistar; Ribonucleotides; Transforming Growth Factor beta1; Ultrasonography; Ventricular Dysfunction, Left | 2009 |